Bg pattern

DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Demilos 600 mg/ 2,000 UI Orodispersible Tablets

Calcium / Colecalciferol

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet (see section 4).
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

Contents of the Package Leaflet:

  1. What is Demilos 600 mg/ 2,000 UI and what is it used for
  2. What you need to know before you take Demilos 600 mg/ 2,000 UI
  3. How to take Demilos 600 mg/ 2,000 UI
  4. Possible side effects
  5. Storage of Demilos 600 mg/ 2,000 UI
  6. Contents of the pack and other information

1. What is Demilos 600 mg/ 2,000 UI and what is it used for

This medicine is used to treat calcium and vitamin D deficiency in adults.

This medicine contains calcium and vitamin D3, both important components in bone formation. Vitamin D3 regulates calcium absorption and metabolism, as well as calcium incorporation into bones.

Ask your doctor or pharmacist if you have any questions and always follow their instructions.

You should consult a doctor if it gets worse or does not improve within a few days.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Demilos 600 mg/ 2,000 UI

Do not take Demilos 600 mg/ 2,000 UI:

  • If you are allergic (hypersensitive) to calcium, vitamin D, or any of the other components of this medicine (listed in section 6).
  • If you have hypercalcemia (high blood calcium levels) or hypercalciuria (high urine calcium levels).
  • If you have hypervitaminosis D (high blood vitamin D levels).
  • If you have kidney stones.
  • If you have kidney failure.
  • If you are pregnant.
  • This medicine contains partially hydrogenated soybean oil. It should not be used in case of peanut or soy allergy.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take Demilos 600 mg/ 2,000 UI.

  • If you have sarcoidosis (a special type of connective tissue disease that affects the lungs, skin, and joints).
  • If you are taking other medicines that contain vitamin D or calcium.
  • If your kidneys do not work well or you have a tendency to form kidney stones.
  • If you are immobilized due to osteoporosis.

Children and Adolescents

Demilos 600 mg/ 2,000 UI is not recommended for use in children or adolescents.

Other Medicines and Demilos 600 mg/ 2,000 UI:

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

The effect of treatment may be affected if this medicine is taken at the same time as other medicines used for:

  • High blood pressure (thiazide diuretics).
  • Heart problems (cardiac glycosides such as digoxin).
  • High cholesterol (cholestyramine).
  • Constipation (laxatives such as liquid paraffin).
  • Epilepsy (phenytoin or barbiturates).
  • Inflammatory diseases / immune system suppression (corticosteroids).
  • Obesity (orlistat).

Please make sure your doctor knows if you are taking any of the medicines listed above. Your dose may need to be adjusted.

If you are taking medicines for:

  • Osteoporosis (bisphosphonates). You should take them at least 3 hours before taking Demilos 600 mg/ 2,000 UI.

If you are taking medicines for:

  • Some infections (quinolones). You should take them 2 hours before or 6 hours after taking Demilos 600 mg/ 2,000 UI.

If you are taking medicines for:

  • Some infections (tetracyclines). You should take them 2 hours before or 4-6 hours after taking Demilos 600 mg/ 2,000 UI.

If you are taking medicines for:

  • Dental caries (sodium fluoride).
  • Anemia (iron), you should take them at least 3 hours before taking Demilos 600 mg/ 2,000 UI.

If you are taking medicines for:

  • Hypothyroidism (levothyroxine), you should space out the intake of Demilos 600 mg/ 2,000 UI by at least 4 hours.

Using Demilos 600 mg/ 2,000 UI with Food, Drinks, and Alcohol:

Calcium absorption may be inhibited by foods containing oxalic acid (found in spinach and rhubarb) or phytic acid (found in most cereals). It is recommended not to take this medicine during the 2 hours following the intake of foods with high oxalic or phytic acid content.

Pregnancy, Breast-feeding, and Fertility:

This medicine is not recommended during pregnancy.

Demilos 600 mg/ 2,000 UI can be taken during breast-feeding. Calcium and vitamin D3 pass into breast milk. This should be taken into account when administering additional vitamin D to the baby. Supplementation with Demilos 600 mg/ 2,000 UI does not replace the administration of vitamin D in newborns.

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.

Driving and Using Machines:

No effects on the ability to drive and use machines have been observed.

Demilos 600 mg/ 2,000 UI contains aspartame, lactose, sucrose, and partially hydrogenated soybean oil

This medicine contains 8.67 mg of aspartame in each tablet.

Aspartame is a source of phenylalanine, which may be harmful in case of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates due to the body's inability to eliminate it properly.

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine. It may cause tooth decay.

This medicine contains soybean oil. It should not be used in case of peanut or soy allergy.

3. How to Take Demilos 600 mg/ 2,000 UI

Follow the instructions for administration of this medicine exactly as prescribed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

The recommended dose is established by your doctor for you individually.

The usual dose is: 1 tablet per day.

The tablets should be dissolved in the mouth. They should not be swallowed whole.

The tablets should be taken preferably after meals.

The amount of calcium in Demilos 600 mg/ 2,000 UI is less than the daily recommended intake. Therefore, this medicine is recommended for patients who need an additional intake of vitamin D but have a daily calcium intake of 500-1,000 mg per day. Your doctor should estimate your daily calcium intake through your diet.

Use in Children and Adolescents

Demilos 600 mg/ 2,000 UI is not indicated for use in children and adolescents.

If You Take More Demilos 600 mg/ 2,000 UI Than You Should:

Call your doctor or pharmacist immediately if you take more of this medicine than prescribed by your doctor. You can also contact the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.

The symptoms of a possible overdose of Demilos 600 mg/ 2,000 UI may include loss of appetite, thirst, excessive urination, nausea, vomiting, and constipation.

If You Forget to Take Demilos 600 mg/ 2,000 UI:

Do not take a double dose to make up for forgotten doses.

Take it as soon as you remember. Then take the next dose as usual. However, if it is already time for your next dose, skip the missed dose and take only one dose as usual.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You should stop taking this medicine and inform your doctor immediately if you experience symptoms of serious allergic reactions such as:

  • Swelling of the face, lips, tongue, or throat.
  • Difficulty swallowing.
  • Hives and difficulty breathing.

Uncommon side effects (may affect up to 1 in 100 people):hypercalcemia (elevated blood calcium levels) and/or hypercalciuria (elevated urine calcium levels).

Rare side effects (may affect less than 1 in 1,000 people):constipation, flatulence, nausea, abdominal distension (pain), diarrhea, pruritus (itching), rash, and urticaria.

Unknown frequency side effects (cannot be estimated from the available data):serious allergic reactions.

Other special populations

Patients with renal insufficiency may have a potential risk of hyperphosphatemia, nephrolithiasis, and nephrocalcinosis.

Reporting of Side Effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Demilos 600 mg/ 2,000 UI

  • Keep this medicine out of the sight and reach of children.
  • Keep the container tightly closed. Do not use this medicine after the expiry date stated on the container, after EXP. The expiry date is the last day of the month stated.
  • Store in the original container to protect from light. Keep the container tightly closed to protect from moisture.
  • The shelf life after first opening is 30 days.
  • Do not use this medicine if you notice any visible signs of deterioration.

Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the Pack and Other Information

Composition of Demilos 600 mg/ 2,000 UI Orodispersible Tablets

The active substances are calcium carbonate 1,500 mg, corresponding to 600 mg of calcium, and colecalciferol 2,000 UI (vitamin D3) corresponding to 0.050 mg.

The other ingredients are: maltodextrin, anhydrous citric acid (E330), low-substituted hydroxypropylcellulose (E463), lactose monohydrate, stearic acid, aspartame (E951), sucrose, gelatin, orange flavor (natural flavorings, maltodextrin, dextrin), corn starch, partially hydrogenated soybean oil, all-rac-α-tocopherol (E307), silicon dioxide.

Appearance of Demilos 600 mg/ 2,000 UI and Contents of the Pack

Orodispersible tablets are white or almost white, circular, and beveled.

Bottle of 30 tablets.

Multi-pack of 60 (2 packs of 30) orodispersible tablets.

Not all pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer:

Marketing Authorization Holder: ITALFARMACO, S.A.

San Rafael, 3 – 28108 Alcobendas (Madrid), SPAIN

Tel.: 916572323

Manufacturer: ITALFARMACO, S.p.A.

Viale Fulvio Testi 330

Milan (ITALY)

Tel.: 39 02 6443.1

This medicine is authorized in the Member States of the European Economic Area under the following names:

  • Italy: Dincrel 600 mg / 2000 U.I. orodispersible tablet
  • Portugal: Demilos Plus 600 mg / 2000 U.I. orodispersible tablets
  • Ireland: Cadelius 600 mg / 2000 U.I orodispersible tablet
  • France: Demilos 600 mg / 2000 U.I. orodispersible tablet

Date of Last Revision of this Leaflet: June 2020

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS

Discuss questions about DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS?
DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
How much does DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS cost in pharmacies?
The average pharmacy price for DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS is around 18.01 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS?
DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS is manufactured by Italfarmaco S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS?
Other medicines with the same active substance () include ADIAVAL 1000 mg/880 IU CHEWABLE TABLETS, BONESIL D FLAS 1500 mg/400 IU ORALLY DISINTEGRATING TABLETS, CADELIUS D 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media